Mainstream Capital Management
PFE icon

Mainstream Capital Management’s Pfizer PFE Stock Holding History

Mainstream Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$84.5K Buy
+2,964
New +$78.8K 0.05% 114
2025
Q1 		– Sell
-30,491
Closed -$809K – 229
2024
Q4 		$809K Sell
30,491
-5,524
-15% -$150K 0.57% 44
2024
Q3 		$1.04M Buy
+36,015
New +$1.05M 0.89% 35

Other funds holding PFE

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Mainstream Capital Management's PFE Position: Q3 2026 in Review

Mainstream Capital Management opened a new position in Pfizer (PFE) in Q3 2026: 2,964 shares worth $84.5K. The stake represents 0.05% of the portfolio and ranks #114 among its holdings. This is a return to the name: Mainstream Capital Management previously reported a position in PFE as recently as Q4 2024.

Mainstream Capital Management first reported a position in PFE in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.04M in Q3 2024. 2,309 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Mainstream Capital Management held 2,964 shares of Pfizer worth $84.5K as of Q3 2026.
  • Pfizer was a new Mainstream Capital Management position in Q3 2026.
  • Pfizer made up 0.05% of Mainstream Capital Management's portfolio in Q3 2026, its #114 holding.
  • Mainstream Capital Management first reported a position in Pfizer in Q3 2024 and has held it in 3 quarters since.
  • Mainstream Capital Management's Pfizer position peaked at $1.04M in Q3 2024.
  • 2,309 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Mainstream Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.